Evolution and current status of the subclassification of intermediate hepatocellular carcinoma

The staging and treatment of intermediate hepatocellular carcinoma (HCC) remains controversial. According to the recommendations of Barcelona Clinic Liver Cancer staging system, patients with intermediate HCC are candidates for transcatheter arterial chemoembolization. However, not all patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Peng-Sheng, Wang, Hong, Li, Jian-Shui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061238/
https://www.ncbi.nlm.nih.gov/pubmed/32218891
http://dx.doi.org/10.4240/wjgs.v12.i3.85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061238/
https://www.ncbi.nlm.nih.gov/pubmed/32218891
http://dx.doi.org/10.4240/wjgs.v12.i3.85

Ejemplares similares